130 related articles for article (PubMed ID: 21656667)
1. Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo.
Cheng M; Li Q; Wan T; Hong X; Chen H; He B; Cheng Z; Xu H; Ye T; Zha B; Wu J; Zhou R
J Biomed Mater Res B Appl Biomater; 2011 Oct; 99(1):70-80. PubMed ID: 21656667
[TBL] [Abstract][Full Text] [Related]
2. [Construction of recombinant plasmid pIRES-GM-CSF-IL-21 and its therapeutic effect on orthotopically transplanted liver cancer in mice].
Cheng MR; Li Q; Hong XW; Ye T; He B; Cheng ZJ; Xu HZ; Zha BB
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):661-5. PubMed ID: 22340045
[TBL] [Abstract][Full Text] [Related]
3. Galactosylated chitosan-graft-polyethylenimine as a gene carrier for hepatocyte targeting.
Jiang HL; Kwon JT; Kim YK; Kim EM; Arote R; Jeong HJ; Nah JW; Choi YJ; Akaike T; Cho MH; Cho CS
Gene Ther; 2007 Oct; 14(19):1389-98. PubMed ID: 17637795
[TBL] [Abstract][Full Text] [Related]
4. Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model.
Dou J; Wang Y; Wang J; Zhao F; Li Y; Cao M; Hu W; Hu K; He XF; Chu L; Jiang C; Gu N
Immunobiology; 2009; 214(6):483-92. PubMed ID: 19389515
[TBL] [Abstract][Full Text] [Related]
5. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
Kim TH; Park IK; Nah JW; Choi YJ; Cho CS
Biomaterials; 2004 Aug; 25(17):3783-92. PubMed ID: 15020154
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte-targeted gene transfection of galactosylated chitosan-graft low molecular polyethyleneimine/DNA complexes.
Tan P; Li M; Wang Y; Feng D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 May; 36(5):369-80. PubMed ID: 21685690
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cell activity of novel galactosylated chitosan as a gene carrier.
Song B; Zhang W; Peng R; Huang J; Nie T; Li Y; Jiang Q; Gao R
Colloids Surf B Biointerfaces; 2009 May; 70(2):181-6. PubMed ID: 19201167
[TBL] [Abstract][Full Text] [Related]
8. Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector.
Gao S; Chen J; Dong L; Ding Z; Yang YH; Zhang J
Eur J Pharm Biopharm; 2005 Aug; 60(3):327-34. PubMed ID: 15894474
[TBL] [Abstract][Full Text] [Related]
9. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
Wang Q; Zhang L; Hu W; Hu ZH; Bei YY; Xu JY; Wang WJ; Zhang XN; Zhang Q
Nanomedicine; 2010 Apr; 6(2):371-81. PubMed ID: 19699319
[TBL] [Abstract][Full Text] [Related]
10. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].
Guo C; Liu QG; Yang W; Yao YM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):188-92. PubMed ID: 18250039
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
Cheng M; Ma D; Zhi K; Liu B; Zhu W
Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
[TBL] [Abstract][Full Text] [Related]
12. Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice.
Tan L; Han S; Ding S; Xiao W; Ding Y; Qian L; Wang C; Gong W
Int J Nanomedicine; 2017; 12():3095-3107. PubMed ID: 28450784
[TBL] [Abstract][Full Text] [Related]
13. Preparation of galactosylated chitosan/tripolyphosphate nanoparticles and application as a gene carrier for targeting SMMC7721 cells.
Jiang H; Wu H; Xu YL; Wang JZ; Zeng Y
J Biosci Bioeng; 2011 Jun; 111(6):719-24. PubMed ID: 21334972
[TBL] [Abstract][Full Text] [Related]
14. Galactosylated chitosan (GC)-graft-poly(vinyl pyrrolidone) (PVP) as hepatocyte-targeting DNA carrier: in vitro transfection.
Park IK; Jiang HL; Cook SE; Cho MH; Kim SI; Jeong HJ; Akaike T; Cho CS
Arch Pharm Res; 2004 Dec; 27(12):1284-9. PubMed ID: 15648108
[TBL] [Abstract][Full Text] [Related]
15. Activation of cellular immunity and marked inhibition of liver cancer in a mouse model following gene therapy and tumor expression of GM-SCF, IL-21, and Rae-1.
Cheng M; Zhi K; Gao X; He B; Li Y; Han J; Zhang Z; Wu Y
Mol Cancer; 2013 Dec; 12(1):166. PubMed ID: 24350772
[TBL] [Abstract][Full Text] [Related]
16. [GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
He SB; Sun K; Wang L; Li DC; Zhang YY
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):410-4. PubMed ID: 20819479
[TBL] [Abstract][Full Text] [Related]
17. Galactosylation of chitosan-graft-spermine as a gene carrier for hepatocyte targeting in vitro and in vivo.
Kim JH; Kim YK; Arash MT; Hong SH; Lee JH; Kang BN; Bang YB; Cho CS; Yu DY; Jiang HL; Cho MH
J Nanosci Nanotechnol; 2012 Jul; 12(7):5178-84. PubMed ID: 22966542
[TBL] [Abstract][Full Text] [Related]
18. Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting.
Gao S; Chen J; Xu X; Ding Z; Yang YH; Hua Z; Zhang J
Int J Pharm; 2003 Apr; 255(1-2):57-68. PubMed ID: 12672602
[TBL] [Abstract][Full Text] [Related]
19. In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery.
Pan PY; Li Y; Li Q; Gu P; Martinet O; Thung S; Chen SH
Cancer Immunol Immunother; 2004 Jan; 53(1):17-25. PubMed ID: 12955480
[TBL] [Abstract][Full Text] [Related]
20. [Effect of Fluorouracil-inducible GM-CSF gene therapy regulated by Egr-1 promoter on chemotherapeutic hematopoietic damage of tumor-bearing mice].
Du N; Pei XT; Xiao WH; Sun JZ; Fu Y; Zhao H; Wang XL
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1281-6. PubMed ID: 19595187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
